10 Years of mouse cancer modifier loci: Human relevance

Cancer Research

Volumn 63, Issue 12, 2003, Pages 3011-3018

  Dragani, Tommaso A ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER; CANCER GENETICS; CANCER MODIFIER LOCUS; CANCER RESISTANCE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; DISEASE MODEL; GENE LOCUS; GENE MAPPING; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TISSUE SPECIFICITY; TUMOR CELL; TUMOR GROWTH;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME MAPPING; CROSSES, GENETIC; EPISTASIS, GENETIC; GENES, P16; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, NATURAL; LINKAGE DISEQUILIBRIUM; MICE; MICE, INBRED STRAINS; NEOPLASMS, EXPERIMENTAL; PARATHYROID HORMONE-RELATED PROTEIN; PEPTIDE HORMONES; PHOSPHOLIPASES A; PROTEIN-TYROSINE-PHOSPHATASE; SPECIES SPECIFICITY;

EID: 0037732512     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (129)

1. Dragani, T. A., and Pierotti, M. A. Animal models to look for polygenic effects in cancer predisposition. In: B. A. J. Ponder and M. J. Waring (eds.), The Genetics of Cancer, vol. 4, pp. 111-122. Dordrecht: Kluwer, 1995.
2. Heston, W. E. Genetic analysis of susceptibility to induced pulmonary tumors in mice. J. Natl. Cancer Inst., 3: 69-78, 1942.
3. Bloom, J. L., and Falconer, D. S. A gene with major effect on susceptibility to induced lung tumors in mice. J. Natl. Cancer Inst., 33: 607-618, 1964.
4. Meruelo, D., Offer, M., and Flieger, N. Genetics of susceptibility for radiation-induced leukemia. Mapping of genes involved to chromosomes 1, 2, and 4, and implications for a viral etiology in the disease. J. Exp. Med., 154: 1201-1211, 1981.
5. Angel, J. M., Morizot, D. C., and Richie, E. R. Genetics of N-methyl-N-nitrosourea induction of thymic lymphomas in AKR/J mice: assignment of a susceptibility gene to mouse chromosome 7. J. Natl. Cancer Inst., 81: 1652-1655, 1989.
6. Dietrich, W., Katz, H., Lincoln, S. E., Shin, H. S., Friedman, J., Dracopoli, N., and Lander, E. S. A genetic map of the mouse suitable for typing intraspecific crosses. Genetics, 131: 423-447, 1992.
7. Gariboldi, M., Manenti, O., Canzian, F., Falvella, F. S., Pieroti, M. A., Della Porta, G. Binelli, G., and Dragani, T. A. Chromosome mapping of murine susceptibility loci to liver carcinogenesis. Cancer Res., 53: 209-211, 1993.
8. Gariboldi, M., Manenti, G., Canzian, F., Falvella, F. S., Radice, M. T. Pierotti, M. A., Della Porta, G., Binelli, G., and Dragani, T. A. A major susceptibility locus to murine lung carcinogenesis maps on chromosome 6. Nat. Genet., 3: 132-136, 1993.
9. Mock, B. A., Krall, M. M., and Dosik, J. K. Genetic mapping of tumor susceptibility genes in mouse plasmacytomagenesis. Proc. Natl. Acad. Sci. USA, 90: 9499-9503, 1993.
10. Dietrich, W. F., Lander, E. S., Smith, J. S., Moser, A. R., Gould, K. A., Luongo, C., Borenstein, N., and Dove, W. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell, 75: 631-639, 1993.
11. Manenti, G., Binelli, G., Gariboldi, M., Canzian, F., De Gregorio, L., Falvella, F. S., Dragani, T. A., and Pierotti, M. A. Multiple loci affect genetic predisposition to hepatocarcinogenesis in mice. Genomics, 23: 118-124, 1994.
12. De Miglio, M. R., Canzian, F., Pascale, R. M., Simile, M. M., Muroni, M. R., Calvisi, D., Romeo, G., and Feo, F. Identification of genetic loci controlling hepatocarcinogenesis on rat chromosomes 7 and 10. Cancer Res., 59: 4651-4657, 1999.
13. Ushijima, T., Yamamoto, M., Suzui, M., Kuramoto, T., Yoshida, Y., Nomoto, T., Tatematsu, M., Sugimura, T., and Nagao, M. Chromosomal mapping of genes controlling development, histological grade, depth of invasion, and size of rat stomach carcinomas. Cancer Res., 60: 1092-1096, 2000.
14. Wood, G. A., Korkola, J. E., and Archer, M. C. Tissue-specific resistance to cancer development in the rat: phenotypes of rumor-modifier genes. Carcinogenesis (Lond.), 23: 1-9, 2002.
15. Manenti, G., Gariboldi, M., Elango, R., Fiorino, A., De Gregorio, L., Falvella, F. S., Hunter, K., Housman, D., Pierotti, M. A., and Dragani, T. A. Genetic mapping of a pulmonary adenoma resistance locus (Par1) in mouse. Nat. Genet., 12: 455-457, 1996.
16. Manenti, G., Gariboldi, M., Fiorino, A., Zanesi, N., Pierotti, M. A., and Dragani, T. A. Genetic mapping of lung cancer modifier loci specifically affecting tumor initiation and progression. Cancer Res., 57: 4164-4166, 1997.
17. Tripodis, N., Hart, A. A., Fijneman, R. J., and Demant, P. Complexity of lung cancer modifiers: mapping of thirty genes and twenty-five interactions in half of the mouse genome. J. Natl. Cancer Inst., 93: 1484-1491, 2001.
18. Gould, K. A., Dietrich, W. F., Borenstein, N., Lander, E. S., and Dove, W. F. Mom1 is a semi-dominant modifier of intestinal adenoma size and multiplicity in Min/+ Mice. Genetics, 144: 1769-1776, 1996.
19. Nagase, H., Mao, J. H., and Balmain, A. A subset of skin tumor modifier loci determines survival time of rumor-bearing mice. Proc. Natl. Acad. Sci. USA, 96: 15032-15037, 1999.
20. Fisher, R. A. The correlation between relatives on the supposition of Mendelian inheritance. Trans. Roy. Sco. Edinburgh, 52: 399-433, 1918.
21. Frankel, W. N., and Schork, N. J. Who's afraid of epistasis? Nat. Genet., 14: 371-373, 1996.
22. Groot, P. C., Moen, C. J. A., Dietrich, W., Stoye, J. P., Lander, E. S., and Demant, P. The recombinant congenic strains for analysis of multigenic traits: genetic composition. FASEB J., 6: 2826-2835, 1992.
23. Fijneman, R. A., de Vries, S. S., Jansen, R. C., and Demant, P. Complex interactions of new quantitative trait loci. Sluc1, Sluc2, Sluc3, and Sluc4, that influence the susceptibility to lung cancer in the mouse. Nat. Genet., 14: 465-470, 1996.
24. Nagase, H., Mao, J. H., de Koning, J. P., Minami, T., and Balmain, A. Epistatic interactions between skin tumor modifier loci in interspecific (spretus/musculus) backcross mice. Cancer Res., 61: 1305-1308, 2001.
25. Wagner, G. P., Laubichler, M. D., and Bagberi-Chaichian, H. Genetic measurement theory of epistatic effects. Genetica, 102-103: 569-580, 1998.
26. Gibson, G. Epistasis and pleiotropy as natural properties of transcriptional regulation. Theor. Popul. Biol., 49: 58-89, 1996.
27. Markel, P., Shu, P., Ebeling, C., Carlson, G. A., Nagle, D. L., Smutko, J. S., and Moore, K. J. Theoretical and empirical issues for marker-assisted breeding of congenic mouse strains. Nat. Genet., 17: 280-284, 1997.
28. Manenti, G., Stafford, A., De Gregorio, L., Gariboldi, M., Falvella, F. S., Avner, P., and Dragani, T. A. Linkage disequilibrium and physical mapping of Pas1 in mice. Genome Res., 9: 639-646, 1999.
29. Min-induced intestinal neoplasia. Cell, 81: 957-966, 1995.
30. Cormier, R., Hong, K., Halberg, R., Hawkins, T., Richardson, P., Mulherkar, R., Dove, W., and Lander, E. S. Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nat. Genet., 17: 88-91, 1997.
31. Cormier, R. T., Bilger, A., Lillich, A. J., Halberg, R. B., Hong, K. H., Gould, K. A., Borenstein, N., Lander, E. S., and Dove, W. F. The Mom1 AKR intestinal tumor resistance region consists of Pla2g2a and a locus distal to D4Mit64. Oncogene, 19: 3182-3192, 2000.
32. Hernandez, M., Fuentes, L., Fernandez Aviles, F. J., Crespo, M. S., and Nielo, M. L. Secretory phospholipase A(2) elicits proinflammatory changes and upregulates the surface expression of fas ligand in monocytic cells: potential relevance for atherogenesis. Circ. Res., 90: 38-45, 2002.
33. Manenti, G., Peissel, B., Gariboldi, M., Falvella, F. S., Zaffaroni, D., Allaria, B., Pazzaglia, S., Rebessi, S., Covelli, V., Saran, A., and Dragani, T. A. A cancer modifier role for parathyroid hormone-related protein. Oncogene, 19: 5324-5328, 2000.
34. Strewler, G. J. The physiology of parathyroid hormone-related protein. N. Engl. J. Med., 342: 177-185, 2000.
35. Potter, M., Mushinski, E. B., Wax, J. S., Hartley, J., and Mock, B. A. Identification of two genes on chromosome 4 that determine resistance to plasmacytoma induction in mice. Cancer Res., 54: 969-975, 1994.
36. Zhang, S. L., DuBois, W., Ramsay, E. S., Bliskovski, V. Morse, H. C., III, Taddesse-Heath, L., Vass, W. C., DePinho, R. A., and Mock, B. A. Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility. Mol. Cell. Biol., 21: 310-318, 2001.
37. Zhang, Z., Wang, Y., Herzog, C. R., Liu, G., Lee, H. W. DePinho, R. A., and You, M. A strong candidate gene for the Papg1 locus on mouse chromosome 4 affecting lung tumor progression. Oncogene, 21: 5960-5966, 2002.
38. Serrano, M. The tumor suppressor protein p16INK4a. Exp. Cell Res., 237: 7-13, 1997.
39. Moen, C. J., Groot, P. C., Hart, A. A., Snoek, M., and Demant, P. Fine mapping of colon tumor susceptibility (Scc) genes in the mouse, different from the genes known to be somatically mutated in colon cancer. Proc. Natl. Acad. Sci. USA, 93: 1082-1086, 1996.
40. Ruivenkamp, C. A., van Wezel, T., Zanon, C., Stassen, A. P., Vlcek, C., Csikos, T., Klous, A. M., Tripodis, N., Perrakis, A., Boerrigter, L., Groot, P. C., Lindeman, J., Mooi, W. J., Meijjer, G. A., Scholten, G., Dauwerse, H., Paces, V., van Zandwijk, N., van Ommen, G. J., and Demant, P. Ptprj is a candidate for the mouse colon-cancer susceptibility locus SccI and is frequently deleted in human cancers. Nat. Genet., 31: 295-300, 2002.
41. Condamine, H., Custer, R. P., and Mintz, B. Pure-strain and genetically mosaic liver tumors histochemically identified with the -glucuronidase marker in allophenic mice. Proc. Natl. Acad. Sci. USA, 68: 2032-2036, 1971.
42. Novelli, M. R., Wasan, H., Rosewell, I., Bee, J., Tomlinson, J. P., Wright, N. A., and Bodmer, W. F. Tumor burden and clonality in multiple intestinal neoplasia mouse/normal mouse aggregation chimeras. Proc. Natl. Acad. Sci. USA, 96: 12553-12558, 1999.
43. Wang, Q. S., Walsh, A., Goldsby, J. S., Papanikolaou, A., Bolt, A. B., and Rosenberg, D. W. Preliminary analysis of azoxymethane-induced colon tumorigenesis in mouse aggregation chimeras. Carcinogenesis (Lond.), 20: 691-697, 1999.
44. Silva, S., Sugiyama, H., Babonits, M., Wiener, F., and Klein, G. Differential susceptibility of BALB/c and DBA/2 cells to plasmacytoma induction in reciprocal chimeras. Int. J. Cancer, 49: 224-228, 1991.
45. Lee, G. H., Nomura, K., Kanda, H., Kusakabe, M., Yoshiki, A., Sakakura T., and Kitagawa, T. Strain specific sensitivity to diethylnitrosamine-induced carcinogenesis is maintained in hepatocytes of C3H/HeN in equilibrium with C57BUL/6N chimeric mice. Cancer Res., 51: 3257-3260, 1991.
46. Dragani, T. A., Manenti, G., and Della Porta, G. Quantitative analysis of genetic susceptibility to liver and long carcinogenesis in mice. Cancer Res., 51: 6299-6303, 1991.
47. Santos, J., Montagutelli, X., Acevedo, A., Lopez, P., Vaquero, C., Fernandez, M., Arnau, M. R., Szatanik, M., Salido, E., Guenet, J. L., and Fernandez-Piqueras, J. A new locus for resistance to γ-radiation-induced thymic lymphoma identified using inter-specific consomic and inter-specific recombinant congenic strains of mice. Oncogene, 21: 6680-6683, 2002.
48. Dragani, T. A., Peissel, B., Zanesi, N., Aloisi, A., Dai, Y., Kato, M., Suzuki, H., and Nakashima, I. Mapping of melanoma modifier loci in RET transgenic mice. Jap. J. Cancer Res., 91: 1142-1147, 2000.
49. Pioli, C., Saran, A., Mouton, D., Troiani, C., Doria, G., Covelli, Neveu, T., and Biozzi, G. Genetics of chemical carcinogenesis-II. Papilloma induction and malignant conversion in susceptible (Car-S) and resistant (Car-R) lines of mice produced by bidirectional selective breeding and in their (Car-S X Car-R) F1 hybrids. Carcinogenesis (Lond.), 15: 2629-2635, 1994.
50. Saran, A., Neveu, T., Covelli, V., Mouton, D., Pazzaglia, S., Rebessi, S., Doria, G., and Biozzi, G. Genetics of chemical carcinogenesis: analysis of bidirectional selective breeding inducing maximal resistance or maximal susceptibility to 2-stage skin tumorigenesis in the mouse. Int. J. Cancer, 88: 424-431, 2000.
51. Saran, A., Bouthillier, Y., Pioli, C., Mouton, D. Covelli, V., Doria, G., Neveu, T., and Biozzi, G. Genetics of chemical carcinogenesis-III. Tissue specificity of the genes controlling susceptibility and resistance to skin carcinogenesis in the mouse. Carcinogenesis (Lond.), 17: 2463-2468, 1996.
52. Saran, A., Zaffaroni, D., Pazzaglia, S., Peissel, B., Galbiati, F., Spinola, M., Manenti, G., Zanesi, N., Rebessi, S. Mancuso, M. T., Covelli, V., and Dragani, T. A. Inhibition of both skin and lung tumorigenesis by Car-R mouse-derived cancer modifier loci. Int. J. Cancer, 97: 580-583, 2002.
53. Brose, M. S., Rebbeck, T. R., Calzone, K. A., Stopfer, J. E., Nathanson, K. L., and Weber, B. L. Cancer risk estimates for BRCAI mutation carriers identified in a risk evaluation program. J. Natl. Cancer Inst., 94: 1365-1372, 2002.
54. Murphy, K. M., Brune, K. A., Griffin, C., Sollenberger, J. E., Petersen, G. M., Bansal, R., Hruban, R. H., and Kern, S. E. Evaluation of candidate genes MAP2K4. MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%. Cancer Res., 62: 3789-3793, 2002.
55. Aarnio, M., Sankila, R., Pukkala, E., Salovaara, R., Aaltonen, L. A., de la, C. A., Peltomaki, P., Mecklin, J. P., and Jarvinen, H. J. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int. J. Cancer, 81: 214-218, 1999.
56. Varley, J. M., Evans, D. G., and Birch, J. M. Li-Fraumeni syndrome-a molecular and clinical review. Br. J. Cancer, 76: 1-14, 1997.
57. Curtsinger, J. W., and Khazaeli, A. A. Lifespan. QTLs, age-specificity, and pleiotropy in Drosophila. Mech. Ageing Dev., 123: 81-93, 2002.
58. Leamy, L. J., Pomp, D., Eisen, E. J., and Cheverud, J. M. Pleiotropy of quantitative trait loci for organ weights and limb bone lengths in mice. Physiol. Genomics, 10: 21-29, 2002.
59. Okumoto, M., Nishikawa, R., Imai, S., and Hilgers, J. Genetic analysis of resistance to radiation lymphomagenesis with recombinant inbred strains of mice. Cancer Res., 50: 3848-3850, 1990.
60. Festing, M. F., Lin, L., Devereux, T. R., Gao, F., Yang, A., Anna, C. H. White, C. M., Malkinson, A. M., and You, M. At least four loci and gender are associated with susceptibility to the chemical induction of lung adenomas in A/J x BALB/c mice. Genomics, 53: 129-136, 1998.
61. Lee, G. H., Bennett, L. M., Carabeo, R. A., and Drinkwater, N. R. Identification of hepatocarcinogen-resistance genes in DBA/2 mice. Genetics, 139: 387-395, 1995.
62. Struski, S., Doco-Fenzy, M., and Cornillet-Lefebvre, P. Compilation of published comparative genomic hybridization studies. Cancer Genet. Cytogenet., 135: 63-90, 2002.
63. Pollock, P. M., and Trent, J. M. The genetics of cutaneous melanoma. Clin. Lab. Med., 20: 667-690, 2000.
64. Badzioch, M., Eeles, R., Leblanc, G., Foulkes, W. D., Giles, G., Edwards, S., Goldgar, D., Hopper, J. L., Bishop, D. T., Moller, P., Heimdal, K., Easton, D., and Simard, J. Suggestive evidence for a site specific prostate cancer gene on chromosome 1p36. The CRC/BPG UK Familial Prostate Cancer Study Coordinators and Collaborators. The EU Biomed Collaborators. J. Med. Genet., 37: 947-949, 2000.
65. Sekine, M., Nagata, H., Tsuji, S., Hirai, Y., Fujimoto, S., Hatae, M., Kobayashi, I., Fujii, T., Nagata, I., Ushijima, K., Obata, K., Suzuki, M., Yoshinaga, M., Umesaki, N., Satoh, S., Enomoto, T., Motoyama, S., and Tanaka, K. Localization of a novel susceptibility gene for familial ovarian cancer to chromosome 3p22-p25. Hum. Mol. Genet., 10: 1421-1429, 2001.
66. Kumimoto, H., Hamajima, N., Nishimoto, Y., Matsuo, K., Shinoda, M., Hatooka, S., and Ishizaki, K. L-myc genotype is associated with different susceptibility to lung cancer in smokers. Jpn. J. Cancer Res., 93: 1-5, 2002.
67. Neville, P. J., Conti, D. V., Paris, P. L., Levin, H., Catalona, W. J., Suarez, B. K., Witte, J. S., and Casey, G. Prostate cancer aggressiveness locus on chromosome 7q32-q33 identified by linkage and allelic imbalance studies. Neoplasia, 4: 424-431, 2002.
68. Crabtree, M. D., Tomlinson, I. P., Hodgson, S. V., Neale, K., Phillips, R. K., and Houlston, R. S. Explaining variation in familial adenomatous polyposis: relationship between genotype and phenotype and evidence for modifier genes. Gut, 51: 420-423, 2002.
69. Johns, L. E., and Houlston, R. S. A systematic review and meta-analysis of familial colorectal cancer risk. Am. J. Gastroenterol., 96: 2992-3003, 2001.
70. Pharoah, P. D., Day, N. E., Duffy, S., Easton, D. F., and Ponder, B. A. Family history and the risk of breast cancer: a systematic review and meta-analysis. Int. J. Cancer, 71: 800-809, 1997.
71. Lichienstein, P. Holm, N. V., Verkasalo, P. K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A., and Hemminki, K. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med., 343: 78-85, 2000.
72. Risch, N. The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol. Biomark. Prev., 10: 733-741, 2001.
73. Dragani, T. A., Canzian, F., and Pierotti, M. A. A polygenic model of inherited predisposition to cancer. FASEB J., 10: 865-870, 1996.
74. Pharoah, P. D., Antoniou, A., Bobrow, M., Zimmern, R. L., Easton, D. F., and Ponder, B. A. Polygenic susceptibility to breast cancer and implications for prevention. Nat. Genet., 31: 33-36, 2002.
75. Peto, J. Genetic predisposition to cancer. In: J. Cairns, J. L. Lyon, and M. Skolnick (eds.), Cancer Incidence in Defined Polpulations (Bambury Report 4), pp. 203-213. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1980.
76. Ponder, B. A. J. Inherited predisposition to cancer. Trends Genet., 6: 213-218, 1990.
77. Christensen, P. M., Gotzsche, P. C., and Brosen, K. The sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of lung cancer: a meta-analysis. Eur. J. Clin. Pharm., 51: 389-393, 1997.
78. Houlston, R. S. CYPIA1 polymorphisms and lung cancer risk: a meta-analysis. Pharmacogenetics, 10: 105-114, 2000.
79. d'Errico, A., Malats, N., Vineis, P., and Boffetta, P. Chapter 23. Review of studies of selected metabolic polymorphisms and cancer. In: P. Vineis, N. Malats, M. Lang, A. d'Errico, N. Caporaso, J. Cuzick, and P. Boffetta (eds.), Metabolic Polymorphisms and Suceptibility to Cancer, vol. 148, pp. 323-393. Lyon: IARC Scientific Publications, 1999.
80. Vineis, P., Marinelli, D., Autrup, H., Brockmoller, J., Cascorbi, I., Daly, A. K., Golka, K., Okkels, H., Risch, A., Rothman, N., Sim, E., and Taioli, E. Current smoking, occupation. N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies. Cancer Epidemiol. Biomed. Prev., 10: 1249-1252, 2001.
81. Tomlinson, I. P., Neale, K., Talbot, I. C., Spigelman, A. D., Williams, C. B., Phillips, R. K., and Bodmer, W. F. A modifying locus for familial adenomatous polyposis may be present on chromosome 1p35-p36. J. Med. Genet., 33: 268-273, 1996.
82. Tomlinson, I. P., Beck, N. E., Neale, K., and Bodmer, W. F. Variants at the secretory phospholipase A2 (PLA2G2A) locus: analysis of associations with familial adenomatous polyposis and sporadic colorectal tumours. Ann. Hum. Genet., 60: 369-376, 1996.
83. Manenti, G., De Gregorio, L., Pilotti, S. Falvella, F. S., Incarbone, M., Ravagnani, F., Pierotti, M. A., and Dragani, T. A. Association of chromosome 12p genetic polymorphisms with lung adenocarcinoma risk and prognosis. Carcinogenesis (Lond.), 18: 1917-1920, 1997.
84. Lynch, H. T., Brand, R. E., Hogg, D., Deters, C. A., Fusaro, R. M., Lynch, J. F., Liu, L., Knezetic, J., Lassam, N. J., Goggins, M., and Kern, S. Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome. Cancer (Phila.), 94: 84-96, 2002.
85. Borg, A., Sandberg, T., Nilsson, K., Johansson, O., Klinker, M., Masback, A., Westerdahl, J., Olsson, H., and Ingvar, C. High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J. Natl. Cancer Inst., 92: 1260-1266, 2000.
86. Aitken, J., Welch, J., Duffy, D., Milligan, A., Green, A., Martin, N., and Hayward CDKN2A variants in a population-based sample of Queensland families with melanoma. J. Natl. Cancer Inst., 91: 446-452, 1999.
87. Kumar, R., Smeds, J., Berggren, P., Straume, O., Rozell, B. L., Akslen, L. A., and Hemminki, K. A single nucleotide polymorphism in the 3′untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare. Int. J. Cancer, 95: 388-393, 2001.
88. Straume, O., Smeds, J., Kumar, R., Hemminki, K., and Akslen, L. A. Significant impact of promoter hypermethylation and the 540 C>T polymorphism of CDKN2A in cutaneous melanoma of the vertical growth phase. Am. J. Pathol., 161: 229-237, 2002.
89. Dilworth, G., Liu, L., Stewart, A. K., Berenson, J. R., Lassam, N., and Hogg, D. Germline CDKN2A mutation implicated in predisposition to multiple myeloma. Blood, 95: 1569-1871, 2000.
90. Dragani, T. A., Hirohashi, S., Juji, T., Kawajiri, K., Kihara, M., Ono-Kihara, M., Manenti, G., Nomoto, T., Sugimura, H., Genka, K., Yokota, J., Takahashi, T., Mitsudomi, T., and Nagao, M. Population-based mapping of pulmonary adenoma susceptibility 1 (PAS1) locus. Cancer Res., 60: 5017-5020, 2000.
91. Yanagitani, N., Kohno, T., Sunaga, N., Kunitoh, H., Tamura, T., Tsuchiya, S., Saito, R., and Yokota, J. Localization of a human lung adenocarcinoma susceptibility locus, possibly syntenic to the mouse Pas1 locus, in the vicinity of the D12S1034 locus on chromosome 12p11.2-p12.1. Carcinogenesis (Lond.), 23: 1177-1183, 2002.
92. Healey, C. S., Dunning, A. M., Teare, M. D., Chase, D., Parker, L., Burn, J., Chang-Claude, J., Mannermaa, A., Kataja, V., Huntsman, D. G., Pharoah, P. D., Luben, R. N., Easton, D. F., and Ponder, B. A. A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. Nat. Genet., 26: 362-394, 2000.
93. Lamlum, H., Al Tassan, N., Jaeger, E., Frayling, I., Sieber, O., Reza, F. B., Eckert, M., Rowan, A., Barclay, E., Atkin, W., Williams, C., Gilbert, J., Cheadle, J., Bell, J., Houlston, R., Bodmer, W., Sampson, J., and Tomlinson, I. Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317Q. Hum. Mol. Genet., 9: 2215-2221, 2000.
94. Hall, M. A., Norman, P. J., Thiel, B., Tiwari, H., Peiffer, A., Vaughan, R. W., Prescott, S., Leppert, M., Schork, N. J., and Lanchbury, J. S. Quantitative trait loci on chromosomes 1, 2, 3, 4, 8, 9, 11, 12, and 18 control variation in levels of T and B lymphocyte subpopulations. Am. J. Hum. Genet., 70: 1172-1182, 2002.
95. Thun, M. J., Henley, S. J., and Patrono, C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J. Natl. Cancer Inst., 94: 252-266, 2002.
96. Wielowieyski, A., Brennan, L. A., and Jongstra, J. Tlil, a resistance locus for carcinogen-induced T-lymphoma. Mamm. Genome, 10: 623-627, 1999.
97. Poole, T. M., and Drinkwater, N. R. Two genes abrogate the inhibition of routine hepatocarcinogenesis by ovarian hormones. Proc. Natl. Acad. Sci. USA, 93: 5848-5853, 1996.
98. Drinkwater, N. R. Genetic control of hepatocarcinogenesis in C3H mice. Drug Metab. Rev., 26: 201-205, 1994.
99. van Wezel, T., Stassen, A. P. M., Moen, C. J. A., Hart, A. A. M., van der Valk, M. A., and Demant, P. Gene interaction and single gene effects in colon tumour susceptibility in mice. Nat. Genet., 14: 468-470, 1996.
100. Moen, C. J. A., Snoek, M., Hart, A. A. M., and Demant, P. SCC-1, a novel colon cancer susceptibility gene in the mouse: linkage to CD44 (Ly-24. Pgp-1) on chromosome 2. Oncogene, 7: 563-566, 1992.
101. Higashi, S., Murai, T., Mori, S., Kamoto, T., Yoshitomi, M., Arakawa, Y., Makino, S., Fukushima, S., Yoshida, O., and Hiai, H. Host genes affecting survival period of chemically induced bladder cancer in mice. Cancer Res. Clin. Oncol., 124: 670-676, 1998.
102. van Wezel, T., Ruivenkamp, C. A., Stassen, A. P., Moen, C. J., and Demant, P. Four new colon cancer susceptibility loci. Scc6 to Scc9 in the mouse. Cancer Res., 59: 4216-4218, 1999.
103. Angel, J. M., Popova, N., Lanko, N., Turusov, V. S., and DiGiovanni, J. A locus that influences susceptibility to 1, 2-dimethylhydrazine-induced colon tumors maps to the distal end of mouse chromosome 3. Mol. Carcinog., 27: 47-54, 2000.
104. Le Voyer, T., Rouse, J., Lu, Z., Lifsted, T., Williams, M., and Hunter, K. W. Three loci modify growth of a transgene-induced mammary tumor: suppression of proliferation associated with decreased microvessel density. Genomics, 74: 253-261, 2001.
105. Saito, Y., Ochiai, Y., Kodama, Y., Tamura, Y., Togashi, T., Kosugi-Okano, H., Miyazawa, T., Wakabayashi, Y., Hatakeyama, K., Wakana, S., Niwa, O., and Kominami, R. Genetic loci controlling susceptibility to γ-ray-induced thymic lymphoma. Oncogene, 20: 5243-5247, 2001.
106. Angel, J. M., and Richie, E. R. TIag2. an N-methyl N-nitrosourea susceptibility locus, maps to mouse chromosome 4. Mol. Carcinog., 33: 105-112, 2002.
107. Beamer, W. G., Shultz, K. L., Tennent, B. J., Nadeau, J. H., Churchill, G. A., and Eicher, E. M. Multigenic and imprinting control of ovarian granulosa cell tumorigenesis in mice. Cancer Res., 58: 3694-3699, 1998.
108. Mock, B. A., Hartley, J., Le Tissier, P., Wax, J. S., and Potter, M. The plasmacytoma resistance gene. Pctr2, delays the onset of tumorigenesis and resides in the telomeric region of chromosome 4. Blood, 90: 4093-4098, 1997.
109. Mock, B. A., Lowry, D. T., Rehman, I., Padlan, C., Yuspa, S. H., and Hennings, H. Multigenic control of skin tumor susceptibility in SENCARA/Pt mice. Carcinogenesis (Lond.), 19: 1109-1115, 1998.
110. Lee, G. H., Bugni, J. M., Obata, M., Nishimori, H., Ogawa, K., and Drinkwater, N. R. Genetic dissection of susceptibility to murine ovarian teratomas that originate from parthenogenetic oocytes. Cancer Res., 57: 590-593, 1997.
111. Nagase, H., Bryson, S., Cordell, H., Kemp, C. J., Fee, F., and Balmain, A. Distinct genetic loci control development of benign and malignant skin tumours in mice. Nat. Genet., 10: 424-429, 1995.
112. Peissel, B., Zaffaroni, D., Pazzaglia, S., Manenti, G., Zanesi, N., Zedda, I., Rebessi, S., Covelli, V., Dragani, T. A., and Saran, A. Use of intercross outbred mice and single nucleotide polymorphisms to map skin cancer modifier loci. Mamm. Genome, 12: 291-294, 2001.
113. Angel, J. M., Morizot, D. C., and Richic, E. R. Localization of a novel chromosome 7 locus that suppresses development of N-methyl-N-nitrosurea-induced murine thymic lymphomas. Mol. Carcinog., 7: 151-156, 1993.
114. Yamada, Y., Shisa, H., Matsushiro, H., Kamoto, T., Kohayashi, Y., Kawarai, A., and Hiai, H. T lymphomagenesis is determined by a dominant host gene thymic lymphoma susceptible mouse-1 (TLSM-1) in mouse models. J. Exp. Med., 180: 2155-2162, 1994.
115. Le Voyer, T., Lu, Z., Babh, J., Lifsted, T., Williams, M., and Hunter, K. An epistatic interaction controls the latency of a transgene-induced mammary tumor. Mamm. Genome, 11: 883-889, 2000.
116. Angel, J. M., Beltran, L., Minda, K., Rupp, T., and DiGiovanni, J. Association of a murine chromosome 9 locus (PsII) with susceptibility to mouse akin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Mol. Carcinog., 20: 162-167, 1997.
117. Lin, L., Festing, M. F., Devereux, T. R., Crist, K. A., Christiansen, S. C., Wang, Y., Yang, Svenson, K., Paigen, B., Malkinson, A. M., and You, M. Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene. Exp. Lung Res., 24: 481-497, 1998.
118. Hiai, H., Abujiang, P., and Nishimura, M. Polygenic resistance to mouse pulmonary adenomas. Exp. Lung Res., 26: 617-625, 2000.
119. Jacoby, R. F., Hohman, C., Marshall, D. J., Frick, T. J., Schlack, S., Broda, M., Smutko, J., and Elliott, R. W. Genetic analysis of colon cancer susceptibility in mice. Genomics, 22: 381-397, 1994.
120. Muller, A. J., Teresky, A. K., and Levine, A. J. A male germ cell tumor-susceptibility-determining locus, pgct1, identified on murine chromosome 13. Proc. Natl. Acad. Sci. USA, 97: 8421-8426, 2000.
121. Mori, N., Okumoto, M., and Yamate, J. A susceptibility locus for radiation lymphomagenesis on mouse chromosome 16. J. Radiat. Res., 41: 367-372, 2000.
122. Pataer, A., Kamoto, T., Lu, L. M., Yamada, Y., and Hiai, H. Two dominant host resistance genes to pre-B lymphoma in wild-derived inbred mouse strain MSM/Ms. Cancer Res., 56: 3716-3720, 1996.
123. Zhang, Z., Lin, L., Liu, G., Wang, M., Hill, J., Wang, Y., You, M., and Devereux, T. R. Fine mapping and characterization of candidate lung tumor resistance genes for the Par2 locus on mouse chromosome 18. Exp. Lung Res., 26: 627-639, 2000.
124. Obata, M., Nishimori, H., Ogawa, K., and Lee, G. H. Identification of the Par2 (Pulmonary adenoma resistance) locus on mouse chromosome 18, a major genetic determinant for lung carcinogen resistance in BALB/cByJ mice. Oncogene, 13: 1599-1604, 1996.
125. Lee, G. H., Matsushita, H., and Kitagawa, T. Fine chromosomal localization of the mouse Par2 gene that confers resistance against urethane-induction of pulmonary adenomas. Oncogene, 20: 3979-3985, 2001.
126. Silverman, K. A., Koratkar, R., Siracusa, L. D., and Buchberg, A. M. Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia. Genome Res., 12: 88-97, 2002.
127. Hunter, K. W., Broman, K. W., Voyer, T. L., Lukes, L., Cozma, D., Debies, M. T., Rouse, J., and Welch, D. R. Predisposition to efficient mammary tumor metastic progression is linked to the breast cancer metastasis supressor gene Brms1. Cancer Res., 61: 8866-8872, 2001.
128. Devereux, T. R., Wiseman, R. W., Kaplan, N., Garren, S., Foley, J. F., White, C. M., Anna, C., Watson, M. A., Patel, A., Jarchow, S., Maronpot, R. R., and Anderson, M. W. Assignment of a locus for mouse lung tumor susceptibility to proximal chromosome 19. Mamm. Genome, 5: 749-755, 1994.
129. Ochiai, Y., Tamura, Y., Saito, Y., Matsuki, A., Wakabayashi, Y., Aizawa, Y., Niwa, O., and Kominami, R. Mapping of genetic modifiers of thymic lymphoma development in p53-knockout mice. Oncogene, 22: 1098-1102, 2003.